Molecule Holdings Inc.

Equities

MLCL

CA60855E1097

Non-Alcoholic Beverages

Delayed Canadian Securities Exchange 10:03:22 2024-03-05 am EST 5-day change 1st Jan Change
0.005 CAD -50.00% Intraday chart for Molecule Holdings Inc. -.--% -50.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Molecule Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 CI
Molecule Holdings Inc. Announces Change of Chief Financial Officer CI
Molecule Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023 CI
Molecule Holdings Inc. cancelled the acquisition of Canna-Day Development Inc. from the shareholders of Canna-Day. CI
Molecule Holdings Inc. Auditor Raises 'Going Concern' Doubt CI
Molecule Holdings Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023 CI
Molecule Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022 CI
Molecule Holdings Inc. has entered into a non-binding letter of intent to acquire Canna-Day Development Inc. from the shareholders of Canna-Day for CAD 0.75 million. CI
Molecule Holdings Inc. announced that it expects to receive CAD 3.75 million in funding CI
Molecule Holdings Inc. Launches New Products CI
Molecule Holdings Inc. Announces Embody Launch in British Columbia CI
Molecule Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022 CI
Molecule Holdings Reports Brokered Private Placement of Convertible Debenture Units; Down 9.1% MT
Molecule Holdings Inc. announced that it expects to receive CAD 3 million in funding CI
Molecule Holdings Inc. announced that it has received CAD 0.6 million in funding CI
Molecule Holdings Inc. Announces PHRESH Launch in British Columbia CI
Molecule Holdings Inc. Announces Partnership with Humble Cannabis Solutions CI
Molecule Holdings Inc. Announces New Skus Available for Purchase Now with OCS CI
Molecule Holdings Inc. Reports Earnings Results for the First Quarter Ended January 31, 2022 CI
Molecule Holdings Inc. Auditor Raises 'Going Concern' Doubt CI
Molecule Holdings Inc. Reports Earnings Results for the Full Year Ended October 31, 2021 CI
Molecule Holdings Inc. Announces British Columbia Liquor Distribution Branch Placed Third Order for the Product: Canajo Espresso Spice CI
Molecule Holdings Inc. to Launch Seven New Products in the Ontario Cannabis Store for Spring and Summer CI
Molecule Holdings Receives a New Purchase Order from Nunavut CI
Molecule Holdings Inc. Announces Addition of its Newest Brand Embody CI
Chart Molecule Holdings Inc.
More charts
Molecule Holdings Inc. is a Canada-based licensed producer engaged in creating cannabis-infused beverages (CIBs) for the Canadian market. The Company operates through one segment being the production and co-packing CIBs. The Company produces drinks to provide opportunity and choice for people seeking a convenient and social way to consume cannabis. Its brands include PHRESH, embody, CANAJO and KLON. It is also focused on growing both its portfolio, and the overall cannabis beverage market.
More about the company
  1. Stock Market
  2. Equities
  3. MLCL Stock
  4. News Molecule Holdings Inc.
  5. Molecule Holdings Reports Brokered Private Placement of Convertible Debenture Units; Down 9.1%